Ensuring the world has fair and equal access to healthcare is one of the defining challenges of our time. Rapid advances in AI, biotech and data analytics are all boosting the speed with which drugs are developed, while closer collaboration between researchers, industry and regulators is cutting the time it takes for new medicines to get to market. Yet even the most groundbreaking treatments are only as effective as the logistics systems that deliver them. And when healthcare supply chains falter, it’s invariably patients who are left counting the cost.

The World Health Organisation (WHO) estimates that up to 50% of vaccines are wasted globally every year, due in large part to supply networks that cannot support an unbroken cold chain. WHO and UNICEF figures also show that around one in three countries experiences at least one national-level vaccine stockout every year

Predictably unpredictable

These problems are not new. The COVID-19 pandemic revealed just how susceptible healthcare supply chains can be to sudden, unanticipated change. Demand spikes, border closures, restricted airfreight capacity and uneven cold chain performance all contributed to a perfect storm of shortages and delays. It also exposed structural weaknesses in procurement processes, distribution networks and international coordination.

Fast forward to today and some of these legacy issues have been resolved. Many healthcare organisations have taken steps to diversify their supply chain while reducing reliance on “just-in-time” global sourcing. This, in turn, has boosted their resilience to unplanned disruptions, especially those affecting a single provider or location. Worldwide coordination at a scientific level is improving.

Yet fresh vulnerabilities have emerged. Climate-related shocks, such as heatwaves, storms and flooding, increasingly disrupt transport routes and compromise temperature-controlled storage. Geopolitical tensions add further unpredictability, influencing customs clearance times, freight availability and the movement of essential raw materials. Growth in biologics and other temperature-sensitive therapies demands tighter oversight and dispersed distribution models that many existing networks currently cannot support.

Asia in the spotlight

These challenges are reflected across healthcare systems everywhere. Asia is an especially powerful case in point. The continent’s vast geographic diversity regularly requires medicines to travel long distances, often with limited cold chain capacity. This means remote and rural populations tend to experience longer delays in receiving medicines.

Inconsistent road networks, language barriers and extreme weather events further complicate distribution to underserved communities, often during times of acute or heightened need. As recently as August this year, the Pakistan Medical Association warned of an unprecedentedly severe shortage of essential medicines across the country. While in Sri Lanka, ongoing supply chain issues have resulted in patients missing drugs for cancer, diabetes and kidney conditions.

Other challenges are systemic. Regulatory reform varies significantly across the region, making standardised trading approaches complex and costly for international providers. Meanwhile, larger countries, like Indonesia and India, must manage multilayered delivery networks that see medicines and vaccines move through national warehouses, regional stores, district depots and local facilities – all before reaching clinics, pharmacies and community health workers. With each layer tending to manage its own inventory, storage and transport processes, the result is a long and fragmented chain featuring multiple potential breaking points.

From fragility to opportunity

While the challenges may be significant, this historic fragility also brings future opportunity. By working closely with logistics partners, healthcare providers – both in Asia and beyond – can replace traditional, linear supply models with fully integrated networks designed for agility, transparency and resilience.

It’s starting to happen already. In Indonesia, the use of a digital tracking system called SMILE is reducing vaccine stock-outs and product wastage while improving reliability even in provinces where cold chain infrastructure has traditionally been inconsistent.

Further afield, in the Pacific Islands, UNICEF and national health agencies have successfully deployed solar-powered cold-chain refrigerators to extend safe storage and deliver essential vaccines to remote and off-grid communities. And during a cholera outbreak in Ethiopia, a medical aid warehouse and kitting lines were used to produce 65 WHO relief kits in just one week, helping at least 6,500 people in need.

Such examples show how targeted investment, innovation and local partnerships can bolster and streamline supply chains even in challenging operating environments and under the most demanding conditions.

Four pillars of success

These modern, resilient and agile logistics systems will be built on four key pillars: collaboration, infrastructure, localisation and innovation. And of the four, collaboration provides the foundation.

Large-scale healthcare logistics must seamlessly connect every link in the supply chain, and this requires a coordinated effort across public and private sectors. When stakeholders are aligned on expectations of quality, compliance and response time, the result is better forecasting, smoother regulatory navigation and more efficient movement of temperature-sensitive products. Closer collaboration also enables clearer communication channels, faster decision-making and more transparent data flows. All of which will be vital to reducing delays, avoiding stockouts as therapies become more complex, and supply chains more fragmented.

Infrastructure is equally critical. GDP-compliant warehousing, reliable cold-chain facilities, multimodal transport routes and strategically placed distribution hubs all underpin temperature security and operational efficiency. In Germany, for example, dedicated healthcare logistics hubs connected to Frankfurt’s air-road corridor have accelerated the movement of biologics and other sensitive products.

As for localisation, it ensures that global capability works effectively on the ground by connecting high-level supply-chain design to practical, day-to-day execution. In particular, it means aligning international networks to local regulatory nuances, customs procedures, cultural expectations and infrastructure constraints. Local insight also strengthens forecasting accuracy and risk management, helping identify potential bottlenecks long before they become service interruptions. As supply chains expand into more remote or underserved regions, localisation becomes essential for maintaining compliance, preserving product integrity and ensuring continuity of care.

Finally, innovation – the glue that binds these elements together. For some years now, digitisation has been shifting healthcare logistics from reactive to proactive, giving organisations greater confidence in the resilience and flexibility of their supply chains. Technologies like IoT sensors, integrated control towers and real-time monitoring all offer true end-to-end visibility, making it easier to track goods and alert stakeholders to deviations. Predictive planning solutions also support dynamic routing and inventory decisions by helping providers anticipate bottlenecks and adjust supply flows to match.

DP World’s work in Nigeria is a good example of innovation being turned into impact. Through an integrated, tech-enabled distribution platform that combines product sourcing, sales and last-mile delivery, the company is able to connect producers with 5,000+ pharmacies. This speeds up communication and makes it easier to track essential products right into the hands of patients. It also offers a replicable solution for healthcare providers in Asian markets where infrastructure remains disjointed.

Sustained success

These four pillars also share an underlying message – namely that agility is most effective when it is built into systems from the very beginning, not just in response to disruptions. And the same goes for the other pressing issue set to reshape healthcare logistics networks in the future.

According to the WHO’s Health Care Climate Footprint Report, the global health sector accounts for nearly 5% of greenhouse gas emissions, with a substantial share linked to logistics activity. As organisations seek to decarbonise, supply chains must be designed to reduce environmental impact without compromising on product integrity.

The good news is that efficiency and sustainability often go hand in hand. Optimised routing, consolidated shipments, cleaner energy use and alternative transport modes all reduce emissions while at the same time strengthening reliability. In many off-grid regions, solar-powered cold chain refrigeration is enabling safer storage and delivery of vaccines and other temperature-sensitive medical products. Similarly, in European logistics, some modern distribution centres powered by renewables offer a promising blueprint for reconciling environmental performance with cold chain reliability.

Regardless, sustainability can no longer be a future ambition for healthcare providers and their logistics partners. As the complexity and capacity of therapies increase, integrating sustainability into the core of supply chain design will be essential to maintaining compliance, earning trust and ultimately, supporting socio-economic progress and growth.

A system that works for everybody

So what does this mean for the future? Clearly, the global healthcare logistics industry is undergoing rapid transformation. Digitalisation, multimodal design, localised expertise and cross-sector collaboration will continue to reshape how medicines are stored, transported and deployed.

Agility must therefore be the overriding feature of tomorrow’s successful supply chains, enabling healthcare systems to deliver reliably, flexibly and effectively even in the face of disruption. This is true whether they operate in an established market or an underserved community.

The future will not be won by a single system or technology. It will be defined by the sector’s collective ability to reimagine the networks that connect patients with the life-changing medical treatments they need. When supply chains are agile, resilient and inclusive, healthcare becomes equitable, and treatment outcomes improve. That system works for everybody.

--AHHM Issue 71--